Allegion - ALLE Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Allegion in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ALLE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ALLE, but not buy additional shares or sell existing shares.
View ALLE analyst ratings or view top-rated stocks.

10 Wall Street analysts have issued 12-month price targets for Allegion's stock. Their ALLE share price forecasts range from $110.00 to $132.00. On average, they expect the company's share price to reach $122.78 in the next twelve months. This suggests a possible upside of 19.9% from the stock's current price.
View analysts price targets for ALLE or view top-rated stocks among Wall Street analysts.

Allegion's stock was trading at $105.26 on January 1st, 2023. Since then, ALLE stock has decreased by 2.7% and is now trading at $102.40.
View the best growth stocks for 2023 here.

Allegion saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 1,540,000 shares, an increase of 14.9% from the February 28th total of 1,340,000 shares. Based on an average daily volume of 713,700 shares, the short-interest ratio is currently 2.2 days. Currently, 1.8% of the shares of the stock are sold short.
View Allegion's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023.
View our ALLE earnings forecast.

Allegion plc (NYSE:ALLE) announced its quarterly earnings data on Wednesday, February, 22nd. The scientific and technical instruments company reported $1.60 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.38 by $0.22. The scientific and technical instruments company earned $861.50 million during the quarter, compared to the consensus estimate of $849.15 million. Allegion had a trailing twelve-month return on equity of 61.54% and a net margin of 14.00%. The firm's revenue for the quarter was up 21.5% compared to the same quarter last year. During the same period last year, the company earned $1.11 EPS.
Read the conference call transcript.

Allegion declared a quarterly dividend on Thursday, February 9th. Investors of record on Wednesday, March 15th will be given a dividend of $0.45 per share on Friday, March 31st. This represents a $1.80 annualized dividend and a dividend yield of 1.76%. The ex-dividend date is Tuesday, March 14th. This is a positive change from the stock's previous quarterly dividend of $0.41.
Read our dividend analysis for ALLE.

ETFs with the largest weight of Allegion (NYSE:ALLE) stock in their portfolio include SPDR S&P Homebuilders ETF (XHB), VanEck Morningstar Wide Moat ETF (MOAT), Invesco S&P 500 Equal Weight Industrials ETF (RGI), Democratic Large Cap Core ETF (DEMZ), VanEck Morningstar ESG Moat ETF (MOTE), Nuveen ESG Mid-Cap Growth ETF (NUMG), Principal Quality ETF (PSET) and Natixis Vaughan Nelson Mid Cap ETF (VNMC).

Allegion (NYSE:ALLE) pays an annual dividend of $1.80 per share and currently has a dividend yield of 1.79%. The company has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 34.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALLE will have a dividend payout ratio of 26.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALLE.

Allegion updated its FY23 earnings guidance on Wednesday, February, 22nd. The company provided earnings per share guidance of $6.30-6.50 for the period, compared to the consensus earnings per share estimate of $6.06. The company issued revenue guidance of +9.0-10.5% yr/yr to ~$3.57-3.62 billion, compared to the consensus revenue estimate of $3.52 billion.

141 employees have rated Allegion Chief Executive Officer David (Dave) D. Petratis on Glassdoor.com. David (Dave) D. Petratis has an approval rating of 90% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Allegion investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Johnson & Johnson (JNJ), Walmart (WMT), Citigroup (C), AT&T (T), UnitedHealth Group (UNH), Cisco Systems (CSCO) and Nucor (NUE).

Allegion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALLE."

Allegion's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Boston Partners (4.59%), AKO Capital LLP (2.95%), Geode Capital Management LLC (2.08%), Ninety One UK Ltd (1.80%), Deutsche Bank AG (1.66%) and Nordea Investment Management AB (1.48%). Insiders that own company stock include David D Petratis, David D Petratis, Douglas P Ranck, Jeffrey N Braun, John H Stone, Patrick S Shannon, Robert C Martens, Shelley A Meador, Timothy P Eckersley, Timothy P Eckersley and Tracy L Kemp.
View institutional ownership trends.

Shares of ALLE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALLE stock can currently be purchased for approximately $102.40.

Allegion (NYSE:ALLE) has a market capitalization of $9.00 billion and generates $3.27 billion in revenue each year. The scientific and technical instruments company earns $458 million in net income (profit) each year or $5.18 on an earnings per share basis.

The company employs 12,300 workers across the globe.

Allegion's mailing address is BLOCK D IVEAGH COURT HARCOURT ROAD, DUBLIN L2, 46032. The official website for the company is www.allegion.com. The scientific and technical instruments company can be reached via phone at (531) 254-6200 or via email at michael.wagnes@allegion.com.